“The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells” (2019) Biomedical Research and Therapy, 6(4), pp. 3131–3140. doi:10.15419/bmrat.v6i4.538.